Whalen Wealth Management Inc. purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 12,455 shares of the company’s stock, valued at approximately $1,600,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Dearborn Partners LLC acquired a new position in shares of Merck KGaA in the second quarter worth about $4,215,000. Trail Ridge Investment Advisors LLC acquired a new stake in shares of Merck KGaA during the 2nd quarter valued at about $697,000. Algert Global LLC increased its stake in shares of Merck KGaA by 11.4% in the 2nd quarter. Algert Global LLC now owns 90,995 shares of the company’s stock valued at $11,693,000 after purchasing an additional 9,323 shares in the last quarter. Ames National Corp acquired a new position in Merck KGaA in the 2nd quarter worth about $1,009,000. Finally, D.B. Root & Company LLC acquired a new position in Merck KGaA in the 2nd quarter worth about $458,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Stock Up 0.1%
Shares of MKGAF opened at $163.45 on Tuesday. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56. The stock’s 50 day moving average is $162.78 and its two-hundred day moving average is $148.59. The firm has a market cap of $21.12 billion, a P/E ratio of 24.95 and a beta of 0.96.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
